Confounding variables in the environmental toxicology of arsenic

Toxicology

Volumn 144, Issue 1-3, 2000, Pages 155-162

  Gebel, T ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Arsenic; Human biomonitoring; Susceptibility

Indexed keywords

ANTIMONY; ARSENIC;

BIOLOGICAL MONITORING; CARCINOGENICITY; DNA METHYLATION; ENZYME POLYMORPHISM; FOOD POISONING; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEA FOOD; SKIN CANCER; XENOBIOTIC METABOLISM; ZINC DEFICIENCY;

EID: 0034599616     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00202-4     Document Type: Article

References (64)

1. Aposhian H.V. Biochemical toxicology of arsenic. Rev. Biochem. Toxicol. 10:1989;265-299.
2. Aposhian H.V., Arroyo A., Cebrian M.E., Del Razo L.M., Hurlbut K.M., Dart R.C., Gonzalez-Ramirez D., Kreppel H., Speisky H., Smith A., Gonsebatt M.E., Ostrosky-Wegman P., Aposhian M.M. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J. Pharmacol. Exp. Ther. 282:1997;192-200.
3. Arbouine M.W., Wilson H.K. The effect of seafood consumption on the assessment of occupational exposure to arsenic by urinary arsenic speciation measurements. J. Trace Elem. Electrolytes Health Dis. 6:1992;153-160.
4. Atadshanov R.S., Kosyneva G.V., Malinovskij V.A., Teshabaiev S., Sultanov M., Risch M.A. Biogeochemische Arsenprovinzen in der UDSSR und Arsengehalt der Pflanzen. Arch. Tierern. 32:1982;377-381.
5. Bailly R., Lauwerys R., Buchet J.P., Mahieu P., Konings J. Experimental and human studies on antimony metabolism: their relevance for the biological monitoring of workers exposed to inorganic antimony. Br. J. Ind. Med. 48:1991;93-97.
6. Basinger M.A., Jones M.M. Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication. Res. Comm. Chem. Pathol. Pharmacol. 32:1981;355-363.
7. Beckman L., Nordenson I. Interaction between some common genotoxic agents. Hum. Hered. 36:1986;397-401.
8. Berry J.P., Galle P. Selenium-arsenic interaction in renal cells: role of lysosomes. Electron microprobe study. J. Submicrosc. Cytol. Pathol. 26:1994;203-210.
9. Biswas S., Talukder G., Sharma A. Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat. Res. 441:1999;155-160.
10. Brown K.G., Chen C.J. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Anal. 15:1995;475-484.
11. Buchet J.P., Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57:1985;125-129.
12. Buchet J.P., Lauwerys R., Roels H. Comparison of several methods for the determination of arsenic compounds in water and in urine. Their application for the study of arsenic metabolism and for the monitoring of workers exposed to arsenic. Int. Arch. Occup. Environ. Health. 46:1980;11-29.
13. Buchet J.P., Pauwels J., Lauwerys R. Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers. Environ. Res. 66:1994;44-51.
14. Chiou H.Y., Hsueh Y.M., Hsieh L.L., Hsu L.I., Hsu Y.H., Hsieh F.I., Wei M.L., Chen H.C., Yang H.T., Leu L.C., Chu T.H., Chen-Wu C., Yang M.H., Chen C.J. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat. Res. 386:1997;197-207.
15. Cole S.P., Sparks K.E., Fraser K., Loe D.W., Grant C.E., Wilson G.M., Deeley R.G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:1994;5902-5910.
16. Crecelius E.A. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19:1977;147-150.
17. Crecelius E.A., Johnson C.J., Hofer G.C. Contamination of soils near a copper smelter by arsenic, antimony and lead. Water Air Soil Pollut. 3:1974;337-342.
18. Das D., Chatterjee A., Mandal B.K., Samanta G., Chakraborti D., Chanda B. Arsenic in ground water in six districts of West bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst. 120:1995;917-924.
19. de Wolff F.A., Edelbroek P.M. Neurotoxicity of arsenic and its compounds. Handbook Clin. Neurol. 20:1994;283-291.
20. Dieter H.H. Vorkommen und Toxikologie von Arsen und seine gesundheitliche Bedeutung im Trinkwasser. Aurand K., Hässelbarth U., Lange-Asschenfeldt H., Steuer W. Die Trinkwasserverordnung. 1991;154-171 Erich Schmidt Verlag, Berlin.
21. Engel R.R., Hopenhayn-Rich C., Receveur O., Smith A.H. Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev. 16(2):1994;184-209.
22. Ewers U., Brockhaus A. Die biologische Überwachung der Schadstoffbelastung des Menschen und ihre Bedeutung bei der Beurteilung umwelttoxikologischer Einflüsse. Gesundheitswesen. 49:1987;639-647.
23. Gebel T. Arsenic and antimony: comparative approach on mechanistic toxicology. Chem. Biol. Interact. 107:1997;131-144.
24. Gebel T. Suppression of arsenic-induced chromosome mutagenicity by antimony in V79 cells. Mutat. Res. 412:1998;213-218.
25. Gebel T. Arsenic and drinking water contamination (letter). Science. 283:1999;1458-1459.
26. Gebel T., Christensen S., Dunkelberg H. Comparative and environmental genotoxicity of antimony and arsenic. Anticancer Res. 17:1997;2603-2607.
27. Gebel T., Schäfer J., Beuermann I., van Platen H., Dunkelberg H. Biomonitoring-Untersuchung bei Personen in Wohngebieten mit erhoehten Bodenwerten an Quecksilber, Arsen und Antimon - Vorstellung und Studiendesign. Forum Staedte Hyg. 4:1995;211-215.
28. Gebel T., Suchenwirth R.H.R., Bolten C., Dunkelberg H. Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure. Environ. Health Perspect. 106:1998;33-39.
29. Hall L.L., George S.E., Kohan M.J., Styblo M., Thomas D.J. In vitro methylation of inorganic arsenic in mouse intestinal cecum. Toxicol. Appl. Pharmacol. 147:1997;101-109.
30. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 104:1996;620-628.
31. Ishikawa T., Bao J.J., Yamane Y., Akimaru K., Frindrich K., Wright C.D., Kuo M.T. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271:1996;14981-14988.
32. Kenyon E.M., Hughes M.F., Levander O.A. Influence of dietary selenium on the disposition of arsenate in the female B6C3F1 mouse. J. Toxicol. Environ. Health. 51:1997;279-299.
33. Kraus R.J., Ganther H.E. Synergistic toxicity between arsenic and methylated selenium compounds. Biol. Trace Elem. Res. 20:1989;105-113.
34. Krause C., Babisch W., Becker K., Bernigau W., Helm D., Hoffmann K. et al. Umwelt-Survey 1990/92, Band Ia: Studienbeschreibung und humanbiologisches Monitoring. WaBoLu Hefte. 1:1996;96.
35. Lerda D. Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat. Res. 312:1994;111-120.
36. Li X., Thornton I. Arsenic, antimony and bismuth in soil and pasture herbage in some old metalliferous mining areas in England. Environ. Geochem. Health. 15:1993;135-144.
37. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277.
38. Moore M.M., Harrington-Brock K., Doerr C.L. Genotoxicity of arsenic and its methylated metabolites. Chapell W.R., Abernathy C.O., Cothern C.R. Arsenic Exposure and Health. 1994;191-198 Science and Technology Letters, Northwood, UK.
39. Moore M.M., Harrington-Brock K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:1997;279-290.
40. Mukhopadhyay R., Dey S., Xu N., Gage D., Lightbody J., Ouellette M., Rosen B.P. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc. Natl. Acad. Sci. USA. 93:1996;10383-10387.
41. Phillips D.J.H. Arsenic in aquatic organisms: a review, emphasizing chemical speciation. Aquat. Toxicol. 16:1990;151-186.
42. Polissar L., Lowry Coble K., Kalman D.A., Hughes J.P., van Belle G., Covert D.S. Pathways of human exposure to arsenic in a community surrounding a copper smelter. Environ. Res. 53:1990;29-47.
43. Pomroy C., Charbonneau S.M., McCullough R.S., Tam G.K. Human retention studies with 74As. Toxicol. Appl. Pharmacol. 53:1980;550-556.
44. Riss A., Schwarz S., Benetka E., Rebler R. Schwermetalle in Böden und Grünlandaufwuchs in der Umgebung einer Kupferhütte in Brixlegg/Tirol. VDI-Berichte. 837:1990;209-223.
45. Rosen B.P., Weigel U., Karkaria C., Gangola P. Molecular characterization of an anion pump. The arsA gene product is an arsenite(antimonate)-stimulated ATPase. J. Biol. Chem. 263:1988;3067-3070.
46. Rudel R., Slayton T.M., Beck B.D. Implications of arsenic genotoxicity for dose response of carcinogenic effects. Regul. Toxicol. Pharmacol. 23:1996;87-105.
47. Schmid K., Lederer P., Schaller K.H., Angerer J., Strebl H., Weber A. Internal exposure to hazardous substances of persons from various countries of origin - investigations on exposure to lead, mercury, arsenic and cadmium. Zentbl. Hyg. Umweltmed. 199:1996;24-37.
48. Schrauzer G.N. Selenium. Mechanistic aspects of anticarcinogenic action. Biol. Trace Elem. Res. 33:1992;51-62.
49. Styblo M., Delnomdedieu M., Thomas D.J. Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem. Biol. Interact. 99:1996;147-164.
50. Tam G.K., Charbonneau S.M., Bryce F., Pomroy C., Sandi E. Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50:1979;319-322.
51. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88:1993;89-114.
52. Trepka M.J., Heinrich J., Schulz C., Krause C., Popescu M., Wjst M., Wichmann H.E. Arsenic burden among children in industrial areas of eastern Germany. Sci. Total Environ. 180:1996;95-105.
53. Vadhanakavit S., Ip C., Ganther H.E. Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. Xenobiotica. 23:1993;731-745.
54. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82:1999;69-88.
55. Vahter M., Concha G., Nermell B., Nilsson R., Dulout F., Natarajan A.T. A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 293:1995;455-462.
56. Vahter M., Lind B. Concentrations of arsenic in urine of the general population in Sweden. Sci. Total Environ. 54:1986;1-12.
57. Wang Z., Dey S., Rosen B.P., Rossman T.G. Efflux-mediated resistance to arsenicals in arsenic-resistant and -hypersensitive Chinese hamster cells. Toxicol. Appl. Pharmacol. 137:1996;112-119.
58. Wu M.M., Kuo T.L., Hwang Y.H., Chen C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130:1989;1123-1132.
59. Zakharyan R.A., Aposhian H.V. Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol. Appl. Pharmacol. 154:1999;287-291.
60. Zakharyan R.A., Ayala-Fierro F., Cullen W.R., Carter D.M., Aposhian H.V. Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15.
61. Zaldivar R. Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. Beitr. Pathol. 151:1974;384-400.
62. Zaldivar R., Guillier A. Environmental and clinical investigations on endemic chronic arsenic poisoning in infants and children. Zentralbl. Bakteriol. (Orig B). 165:1977;226-234.
63. Zhang L., Chen C. Geographic distribution and exposure population of drinking water with high concentration of arsenic in China. Wei Sheng Yen Chiu. 26:1997;310-313. (in Chinese).
64. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA. 94:1997;10907-10912.